Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription 05.10.2026 1 Ann Neurol 1 BMC Neurol 2 Curr Opin Immunol 2 Intern Med 1 J Nephrol 1 J Neuroimmunol 5 J Neurol 4 J Rheumatol 1 Kidney Int 3 Mult Scler 1 N Engl J Med 3 Neurology 1 PLoS Comput Biol 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. MONTINI F, Pittock SJ, Cacciaguerra L, Weiner HL, et al
   Reframing the Gut-Brain Axis: The Gut Wall as a Neural Immune Interface in Multiple Sclerosis and Autoimmune Neurological Diseases.
   Ann Neurol. 2026 Sep 26. doi: 10.1002/ana.78380.
   PubMed         Abstract available
   
   

   
   BMC Neurol

2. SHARIFF S, Mairajuddin SI, Kamran SH, Al Madani AS, et al
   Complex vasculitic overlap: temporal arteritis complicating suspected neuro-behcet disease with recurrent ischemic injury.
   BMC Neurol. 2026 Jul 6. doi: 10.1186/s12883-026-05120.
   PubMed         Abstract available
   
   

   
   Curr Opin Immunol

3. MERONI PL
   Editorial overview: Editorial introduction - Anti-phospholipid antibody syndrome (2025).
   Curr Opin Immunol. 2026;103:102850.
   PubMed        
   
   
4. MOUTSOPOULOS HM
   Autoimmune diseases: distinct disorders or diverse manifestations of a common pathogenic process?
   Curr Opin Immunol. 2026;103:102852.
   PubMed         Abstract available
   
   

   
   Intern Med

5. YOSHIDA S, Nakagomi D, Ueda M, Asahina K, et al
   Biopsy-proven Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-associated Vasculitis Overlap Syndrome Developed during Propylthiouracil Therapy: A Case-based Review.
   Intern Med. 2026 Sep 29. doi: 10.2169/internalmedicine.7792.
   PubMed         Abstract available
   
   
6. NAKAMURA S, Yamada K, Yaguchi H, Kudo A, et al
   Immune Checkpoint Inhibitor Therapy Triggers Autoimmune Cerebellar Ataxia with Anti-P/Q-type VGCC Antibody and Anti-mGluR5 Antibodies: A Case Report.
   Intern Med. 2026 Sep 29. doi: 10.2169/internalmedicine.7680.
   PubMed         Abstract available
   
   

   
   J Nephrol

7. YANG C, Chen P, Xiong J
   Finerenone in IgA nephropathy: A Systematic Review of Real-world Studies.
   J Nephrol. 2026 Sep 30:aajag228. doi: 10.1093.
   PubMed        
   
   

   
   J Neuroimmunol

8. ZHOU J, Zhou L, Song K, Li B, et al
   Early molecular changes in the subfornical organ during experimental autoimmune encephalomyelitis.
   J Neuroimmunol. 2026;421:579103.
   PubMed         Abstract available
   
   

   
   J Neurol

9. KOREN TJ, Dugal J, Wang D, Beadnall H, et al
   Spinal cord imaging in multiple sclerosis: from diagnosis to disease progression.
   J Neurol. 2026;273:634.
   PubMed         Abstract available
   
   
10. NICOLELLA V, Polito C, Criscuolo V, Varelli M, et al
    Evaluating the neurofilament light chain-derived gap between biological and chronological age in multiple sclerosis and controls.
    J Neurol. 2026;273:625.
    PubMed         Abstract available
    
    
11. STAMENKOVIC M, Vukovic I, Milosevic E, Peric S, et al
    The role of leukocyte p38 MAP kinase in immune-mediated peripheral polyneuropathies: distinct modulation by intravenous immunoglobulins.
    J Neurol. 2026;273:627.
    PubMed         Abstract available
    
    
12. HEDSTROM AK, Olsson T, Alfredsson L
    Family history of multiple sclerosis and long-term outcomes.
    J Neurol. 2026;273:622.
    PubMed         Abstract available
    
    
13. GUO Q, Olsson T, Alfredsson L, Hedstrom AK, et al
    Leisure-time physical activity, sun exposure, and multiple sclerosis risk: a population-based case-control study.
    J Neurol. 2026;273:623.
    PubMed         Abstract available
    
    

    
    J Rheumatol

14. NARBERHAUS HM, Tatsis S, Klotsche J, Foeldvari I, et al
    Clinical Correlates of a Successful Transition in Pediatric Rheumatology.
    J Rheumatol. 2026;53:1135-1139.
    PubMed         Abstract available
    
    
15. ARBIV OA, Fidler L, Johnson SR, Gershon AS, et al
    Management of Antineutrophil Cytoplasmic Antibody-Associated Alveolar Hemorrhage: A Bayesian Reanalysis of the PEXIVAS Trial.
    J Rheumatol. 2026;53:1117-1124.
    PubMed         Abstract available
    
    
16. OLIVER M, Mosesso K, Weiss PF, Colbert RA, et al
    Clinical Disease Manifestations Associated With Tumor Necrosis Factor Inhibitor Nonresponse in Juvenile Spondyloarthritis.
    J Rheumatol. 2026;53:1140-1146.
    PubMed         Abstract available
    
    
17. ABOUL-HASSAN D, Alawamleh A, Mahajan N, Bailey B, et al
    Qualitative Analysis of Physical Activity Engagement in Women With Self-Reported Systemic Lupus Erythematosus: The Role of Symptoms, Healthcare Providers, and the Environment.
    J Rheumatol. 2026;53:1098-1108.
    PubMed         Abstract available
    
    

    
    Kidney Int

18. YAP DYH, Navarra SV, Ni Z, Avihingsanon Y, et al
    Prospective 96-week study to evaluate efficacy and safety of tacrolimus and glucocorticoid against mycophenolate and glucocorticoid as continuous induction-maintenance treatment for Class III/IV without or with Class V lupus nephritis.
    Kidney Int. 2026 Sep 28:S0085-2538(26)00817-3. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available
    
    

    
    Mult Scler

19. MARRIE RA, Bolton JM, Ling V, Bernstein CN, et al
    Peripartum mental illness in serial pregnancies in mothers with multiple sclerosis and other chronic diseases.
    Mult Scler. 2026 Sep 30:13524585261486779. doi: 10.1177/13524585261486779.
    PubMed         Abstract available
    
    
20. KUHARIC M, Nowinski C, Perschon CR, Miller CH, et al
    Use of patient reported outcomes in multiple sclerosis clinical management: Scoping literature review.
    Mult Scler. 2026 Sep 29:13524585261481124. doi: 10.1177/13524585261481124.
    PubMed         Abstract available
    
    
21. SCHOENHOLZER K, Sellathurai S, Burguet Villena F, Cerda-Fuertes N, et al
    Retinal vessel diameters in multiple sclerosis: associations with disability, cardiovascular risk factors and retinal atrophy.
    Mult Scler. 2026 Sep 28:13524585261489425. doi: 10.1177/13524585261489425.
    PubMed         Abstract available
    
    

    
    N Engl J Med

22. DELLA-TORRE E, Baker MC, Zhang W, Perugino CA, et al
    Obexelimab for the Treatment of IgG4-Related Disease.
    N Engl J Med. 2026;395:1273-1284.
    PubMed         Abstract available
    
    

    
    Neurology

23. BARTER KM, Thant A, Pitt M, Thotakura V, et al
    Pearls & Oy-sters: Diagnosis of Pediatric Tumefactive Multiple Sclerosis With MRI Biomarkers.
    Neurology. 2026;107:e218575.
    PubMed         Abstract available
    
    
24. JAIN K, Storelli L, Valsasina P, Preziosa P, et al
    Disentangling Age-Related and Disease-Specific Effects on Upper Cervical Cord Area in Patients With Multiple Sclerosis.
    Neurology. 2026;107:e218517.
    PubMed         Abstract available
    
    
25. VRENKEN H
    Separating Disease Effects From Aging in Spinal Cord Atrophy in Multiple Sclerosis.
    Neurology. 2026;107:e218605.
    PubMed        
    
    

    
    PLoS Comput Biol

26. YANG C, Liao Y, Sheng Y, Jiao F, et al
    Integrating zero-inflation correction and transcriptional kinetics for single-cell transcriptomic analysis.
    PLoS Comput Biol. 2026;22:e1014779.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

27. BAIER S, Wang Z, Loll N, Mader S, et al
    T-B interactions yield CD3(+) B cells and CD20(+) T cells with pathogenic features in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2026;123:e2605806123.
    PubMed         Abstract available
    
    
28. VIETZEN H, Waubant EL, Casper TC, Benson LA, et al
    Impaired control of autoimmunity increases pediatric multiple sclerosis risk in EBNA-1-seropositives and -seronegatives.
    Proc Natl Acad Sci U S A. 2026;123:e2607529123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum